Anti PD-L1 (Atezolizumab) as an Immune Primer and Concurrently With Extended Field Chemoradiotherapy for Node Positive Locally Advanced Cervical Cancer
Phase of Trial: Phase I
Latest Information Update: 26 Nov 2019
Price : $35 *
At a glance
- Drugs Atezolizumab (Primary) ; Cisplatin (Primary)
- Indications Adenocarcinoma; Cervical cancer; Squamous cell cancer
- Focus Therapeutic Use
- 22 Nov 2019 Planned End Date changed from 31 Oct 2019 to 1 Nov 2021.
- 22 Nov 2019 Planned primary completion date changed from 31 Oct 2019 to 1 Nov 2021.
- 19 Nov 2018 New trial record